标题:RETRACTED: SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma (Retracted article. See vol. 54, pg. 7550, 2017)
作者:Liao, Anyan; Shi, Ranran; Jiang, Yuliang; Tian, Suqing; Li, Panpan; Song, Fuxi; Qu, Yalan; Li, Jinna; Yun, Haiqin; Yang, Xiangshan
作者机构:[Liao, Anyan; Jiang, Yuliang; Tian, Suqing; Li, Jinna] Peking Univ, Hosp 3, Dept Radiat Oncol, Beijing 100191, Peoples R China.; [Shi, Ranran] Shand 更多
通讯作者:Liao, AY
通讯作者地址:[Liao, AY]Peking Univ, Hosp 3, Dept Radiat Oncol, 49 Hua Yuan Bei Lu, Beijing 100191, Peoples R China.
来源:MOLECULAR NEUROBIOLOGY
出版年:2016
卷:53
期:1
页码:210-215
DOI:10.1007/s12035-014-9006-0
关键词:SDF-1/CXCR4; Survivin; Cell cycle progression; EMT
摘要:Stromal cell-derived factor 1 (SDF-1)/CXCR4 ligand-receptor axis is widely recommended as an attractive target for cancer therapy. Meanwhile, epithelial-mesenchymal transition (EMT) process is linked to disease pathophysiology. As one of inhibitors of apoptosis proteins, survivin is implicated in the onset and development of cancer. In the present study, we tried to determine the cause-effect associations between SDF-1/CXCR4 axis and survivin expression in glioblastoma U-251 cell line. Survivin activation and inhibition were induced with exogenous SDF-1 and survivin small interfering RNA (survivin siRNA), respectively. Western blot was used to detect relevant proteins in SDF-1/CXCR4 axis. Western blot analysis revealed that survivin expression in U-251 increased in a dose- and time-dependent manner in response to SDF-1 treatment. However, the interference with MEK/ERK and PI3K/AKT pathway prohibited SDF-1-induced survivin up-regulation. Importantly, survivin knockdown abrogated cell cycle progression and the expression of snail and N-cadherin, compared with non-transfectants. In conclusion, the present study shows that SDF-1 up-regulates survivin via MEK/ERK and PI3K/AKT pathway, leading to cell cycle progression and EMT occurrence dependent on survivin. The blockade of survivin will allow for the treatment of glioblastoma.
收录类别:SCOPUS;SCIE
WOS核心被引频次:15
Scopus被引频次:17
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953365694&doi=10.1007%2fs12035-014-9006-0&partnerID=40&md5=0d15df38ae2e04344557bcedfdbedd07
TOP